Scopelianos Angelo
Chief R&D Officer at AXGN
- Sold, on record
- $63k
- Dollars the filings state
- Form 4 sales
- 2
- Latest Mar 21, 2024
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- AXGNAxogen, Inc.Chief R&D Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale AXGNPlan not statedDec 29 2020
Sold 567 shares at $17.81 ($10k)
Scopelianos Angelo, VP Research & Development
Sold 9.3% of holdings ($109k position)5,529 shares leftFirst sale on recordFiling
- 2 Form 4 sale AXGNNo planMar 21 +1178 days
Sold 6,881 shares at $7.68 ($53k)
Scopelianos Angelo, Chief R&D Officer
No 10b5-1 planSold 10.6% of holdings ($498k position)57,994 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…